Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/9/24 17:24 | 5/10/22 | PEPG | Health | Drug | Pharmaceutical Preparations | Oxford Science Enterprises Plc | X0 | T | P.a | 10,560 | 12.00 | 0 | 880 | 23 | 4,755 | D | |||||||||||||||
2/13/24 16:33 | 2/9/24 | PEPG | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P | 27,213 | 10.64 | 0 | 2,558 | 31 | 10,690 | I | |||||||||||||||
12/5/23 07:34 | 11/30/23 | PEPG | Health | Drug | Pharmaceutical Preparations | McArthur James G | MA | DO | P,CEO | P | 7 | 4.17 | 0 | 2 | New | 2 | D | ||||||||||||||
1/19/23 17:17 | 5/6/22 | PEPG | Health | Drug | Pharmaceutical Preparations | Keating Laurie | MA | D | P | 50 | 12.00 | 0 | 4 | New | 4 | D | |||||||||||||||
5/12/22 19:06 | 5/10/22 | PEPG | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P.d | 38,750 | 12.00 | 0 | 3,229 | 208 | I | ||||||||||||||||
5/10/22 18:22 | 5/10/22 | PEPG | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | P.d | 5,000 | 12.00 | 0 | 417 | 78 | 954 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |